SE8205035L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE8205035L
SE8205035L SE8205035A SE8205035A SE8205035L SE 8205035 L SE8205035 L SE 8205035L SE 8205035 A SE8205035 A SE 8205035A SE 8205035 A SE8205035 A SE 8205035A SE 8205035 L SE8205035 L SE 8205035L
Authority
SE
Sweden
Prior art keywords
histamine
pharmaceutical compositions
inflammatory drug
antagonist
piperidinylmethyl
Prior art date
Application number
SE8205035A
Other languages
English (en)
Swedish (sv)
Other versions
SE8205035D0 (sv
Inventor
R T Brittain
B J Price
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8205035D0 publication Critical patent/SE8205035D0/xx
Publication of SE8205035L publication Critical patent/SE8205035L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8205035A 1981-09-04 1982-09-03 Farmaceutiska kompositioner SE8205035L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04

Publications (2)

Publication Number Publication Date
SE8205035D0 SE8205035D0 (sv) 1982-09-03
SE8205035L true SE8205035L (sv) 1983-03-05

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8205035A SE8205035L (sv) 1981-09-04 1982-09-03 Farmaceutiska kompositioner

Country Status (18)

Country Link
JP (1) JPS5855421A (da)
KR (1) KR840001276A (da)
AU (1) AU8799882A (da)
BE (1) BE894286A (da)
DE (1) DE3232831A1 (da)
DK (1) DK396582A (da)
FI (1) FI823041L (da)
FR (1) FR2512343A1 (da)
GB (1) GB2105588B (da)
GR (1) GR76433B (da)
IL (1) IL66709A0 (da)
IT (1) IT8249072A0 (da)
LU (1) LU84364A1 (da)
NL (1) NL8203456A (da)
PT (1) PT75504A (da)
SE (1) SE8205035L (da)
ZA (1) ZA826479B (da)
ZW (1) ZW18582A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US20110301116A1 (en) * 2008-12-04 2011-12-08 The University Of Tokyo Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3067920D1 (en) * 1979-03-02 1984-06-28 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
US4410523A (en) * 1979-10-22 1983-10-18 Glaxo Group Limited Heterocyclic derivatives

Also Published As

Publication number Publication date
DE3232831A1 (de) 1983-03-24
FR2512343A1 (fr) 1983-03-11
JPS5855421A (ja) 1983-04-01
IT8249072A0 (it) 1982-09-03
GB2105588A (en) 1983-03-30
GR76433B (da) 1984-08-10
AU8799882A (en) 1983-03-10
BE894286A (fr) 1983-03-02
PT75504A (en) 1982-10-01
FI823041A7 (fi) 1983-03-05
FI823041A0 (fi) 1982-09-03
IL66709A0 (en) 1982-12-31
KR840001276A (ko) 1984-04-30
LU84364A1 (fr) 1984-04-24
NL8203456A (nl) 1983-04-05
DK396582A (da) 1983-03-05
ZA826479B (en) 1984-04-25
ZW18582A1 (en) 1984-03-28
FI823041L (fi) 1983-03-05
SE8205035D0 (sv) 1982-09-03
GB2105588B (en) 1984-07-18

Similar Documents

Publication Publication Date Title
IT8220781A0 (it) Bifosfonati farmacologicamente attivi, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ES511695A0 (es) "un procedimiento para obtener una proteina cristalina de b. thuringiensis".
DE3885957D1 (de) Photographisches Material, das eine neue DIR-Verbindung enthält.
FI802506A7 (fi) Tulehdusta vastustavia 5-substituoituja 2,3-diaryylitiofeenejä.
ES515419A0 (es) Un procedimiento de preparacion de nuevos derivados de 4h-1,2,4-triazol.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
SE8205035D0 (sv) Farmaceutiska kompositioner
IT7920567A0 (it) Meccanismo d'interbloccaggio di formulazione d'indirizzo.
IT8023300A0 (it) Aciluree, mezzi insetticidi contenenti tali composti nonche'procedimento per la loro preparazione.
FI852743A0 (fi) Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni.
IT7927243A0 (it) Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
NZ184806A (en) 1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates
NO880781D0 (no) Monteringsmaskin, saerlig for emballasje formet av utstansede emner.
AU505351B2 (en) 1-[[5-(substituted phenyl)-2-oxazoly] -methylene]-amino]-2,4-imidazolidinediones
FR2675560B1 (fr) Garniture d'etancheite pour arbre rotatif.
ES490144A0 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido.
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ES516639A0 (es) "procedimiento para la obtencion del plasmido pac 1".
ES513429A0 (es) "un procedimiento para la preparacion de una composicion nematocida".
IT8221939A0 (it) Immidazolil-propionitrili, procedimento per la preparazione di questi composti nonche' mezzi biocidi che li contengono.
SE8205034D0 (sv) Farmaceutiska kompositioner
RU93004984A (ru) Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
IT8920285A0 (it) Composti piperidintriazinici atti all'impiego come stabilizzanti per materiali organici.
NO157101C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive anilino-1,2,3-triazol-derivater.
IT8125374A0 (it) Composto antiipertensivo procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8205035-2

Effective date: 19851125